JXR MEDI BARRI JOURNEY
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
- Investigator
- Michael D Schweitzer Barrios
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All
JXR MEDI MORA SPARKLE
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult Sickle Cell Disease…
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All
JXR MEDI CHEH M21-341
This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone [TSH]) on synthetic T4…
- Investigator
- Joe M Chehade
- Status
- Accepting Candidates
- Ages
- Adults
- Sexes
- All